|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |review |
 |
New intervention methods: Assessment of efficacy and safety
of albendazole combinations. New strategies: a) Development of evidence-based guidelines for elimination strategies using available drug combinations. b) Development of improved drug delivery strategies including advocacy strategies. c) Development of sustainable strategies for management of lymphoedema and genito-urinary complications. |